UnitedHealth reported fourth-quarter adjusted EPS of $6.81, up from $6.16 a year ago, beating the consensus of $6.72.

The ASX dropped on Wednesday with banks and MinRes headlining losses. Gold, however, is the play once more as Trump talks ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

The highest price of Vertex Securities Ltd stock is ₹7.36 in the last 52-week ... key details MSCI India rejig: Adani Green Energy out, Hyundai Motor in; Jai Corp sees smallcap index exclusion ...

Trademark Financial Management LLC grew its holdings in Exxon Mobil Co. (NYSE:XOM – Free Report) by 8.5% in the fourth ...

Exxon Mobil Co. (NYSE:XOM – Get Free Report)’s share price traded down 1% on Thursday following insider selling activity. The ...

The Parnassus Growth Equity Fund returned 4.85% (net) for Q4 2024, underperforming the Russell 1000 Growth Index’s 7.07%.

ASX rises with Nvidia and gold's record high, Trump’s tariffs hit, Albanese talks to Trump, Musk’s OpenAI bid blocked.

S&P 500 E-Mini futures are up +0.46%, andMarch Nasdaq 100 E-Mini futures are up +0.61% this morning as investors shrugged off U.S. President Donald Trump’s latest tariff a ...

As the quarterly earnings season continues, the upcoming week promises a flurry of reports from some of the most influential companies spanning various industries. In the consumer sector, Coca-Cola ...

Truist Securities increased the price target for Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ: VRTX), a $121 ...

This anticipated adoption, along with a projected modest market penetration, underpins the increased price target for Vertex Pharmaceuticals’ stock, contributing to Fein’s Buy rating.